Thompson Siegel & Walmsley’s Precigen PGEN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-150	Closed	-$2K	–	776
2020 Q4	$2K	Hold	150	–	–	﹤0.01%	650
2020 Q3	$1K	Hold	150	–	–	﹤0.01%	638
2020 Q2	$1K	Hold	150	–	–	﹤0.01%	647
2020 Q1	$1K	Hold	150	–	–	﹤0.01%	639
2019 Q4	$1K	Hold	150	–	–	﹤0.01%	764
2019 Q3	$1K	Hold	150	–	–	﹤0.01%	717
2019 Q2	$1K	Hold	150	–	–	﹤0.01%	731
2019 Q1	$1K	Hold	150	–	–	﹤0.01%	656
2018 Q4	$1K	Hold	150	–	–	﹤0.01%	738
2018 Q3	$3K	Hold	150	–	–	﹤0.01%	738
2018 Q2	$2K	Hold	150	–	–	﹤0.01%	775
2018 Q1	$2K	Hold	150	–	–	﹤0.01%	774
2017 Q4	$2K	Hold	150	–	–	﹤0.01%	810
2017 Q3	$3K	Hold	150	–	–	﹤0.01%	804
2017 Q2	$4K	Hold	150	–	–	﹤0.01%	773
2017 Q1	$3K	Sell	150 -1	-0.7%	-$22	﹤0.01%	771
2016 Q4	$4K	Hold	151	–	–	﹤0.01%	712
2016 Q3	$4K	Hold	151	–	–	﹤0.01%	686
2016 Q2	$4K	Hold	151	–	–	﹤0.01%	688
2016 Q1	$5K	Hold	151	–	–	﹤0.01%	649
2015 Q4	$5K	Hold	151	–	–	﹤0.01%	657
2015 Q3	$5K	Buy	+151	New	+$7.37K	﹤0.01%	662

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Thompson Siegel & Walmsley's PGEN Position: Q1 2021 in Review

Thompson Siegel & Walmsley sold out of Precigen (PGEN) in Q1 2021, closing a stake of 150 shares — an estimated $2K sold.

Thompson Siegel & Walmsley first reported a position in PGEN in Q3 2015 and held it in 22 quarters. The position peaked at $5K in Q1 2016. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2021.

Thompson Siegel & Walmsley reported no remaining Precigen position as of Q1 2021 after selling out during the quarter.
Thompson Siegel & Walmsley sold 150 Precigen shares in Q1 2021, an estimated $2K.
Thompson Siegel & Walmsley first reported a position in Precigen in Q3 2015 and held it in 22 quarters.
Thompson Siegel & Walmsley's Precigen position peaked at $5K in Q1 2016.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2021.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2021, filed 7 May 2021.